4DIBISCEGLIE A,LAI CL,GANE E,et al. Telbivudine Clobe trial:maximal early HBV suppression is predicitive of optimal two-year efficacy in nucleoside-treated hepatient [J]. Hepatology, 2006,44:230A.
5EMMET B,KEEFFE EB,DOUGLAS T,et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States [J]. Clin Gastroenterol Hepatol, 2008,6:1315-1341.
6PINTI M,SALOMONI P,COSSARIZZA A. Anti-HIV drug and the mitochondria[J]. Biochim Biophys Acta,2006,1757: 700-703.
7LAI CL,GANE E,LIAU YF,et al. Telbivudine versus lamivudine in patients with hepatitis B [J]. N Engl J Med, 2007,357:2576-2588.
8Cullen JM,Li DH,Brown C,et al.Antiviral efficacy and pharmacokinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks[J].Antimicrob Agents Chemofher,2001,45(10):2 740-2 745.
10Hadziyannis S,Tassopoulos N,Chang TT,et al.Three year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B patients in a long-term safety and efficacy study.J Hepatol,2004,40(Suppl 1):17 (Abstract 46).
5Liaw YF,Gane E,Leung N,et al. 2 Year GLOBE trial results:telbi- vudine is superior to Lamivudine in patients with chronic hepatitis B [ J ]. Gastroenterology,2009,136 (2) :486 - 495.
8Stomaiuolo G, Amato A, Gaeta GB. Adefovir dipivoxil associated thrombocytopenia in a patient with chronic hepatitis B. Digestive Liver Dis, 2006, 38:211-212.
9Weber A, Carbonnel F, Simon NA, et al. Severe acute pancreatitis related to the use of adefovir in a liver transplant recipient. Gastroenterol Clini Biol, 2008, 32:247-249.
